Tissue distribution, elimination and metabolism of [3H]-leukotriene C4 in the American bullfrog, Rana catesbeiana. 1993

C A Pfeifer, and R A Furilla, and K Gronert, and D D Goss, and K E Romig, and C A Herman
Department of Biology, New Mexico State University Las Cruces.

Tissue distribution, elimination, and metabolism of [3H]-leukotriene C4 were studied at 2.5 hours after injection in the conscious and anesthetized American bullfrog, Rana catesbeiana. Conscious frogs were injected via the dorsal lymph sac or the sciatic vein. Anesthetized frogs were injected via the abdominal vein. The organs containing the greatest percent of injected radioactivity at 2.5 hours after injection were liver, small intestine and kidney. Route of injection and anesthesia appears to alter distribution and elimination of leukotrienes. [3H]-leukotrienes were eliminated into bladder water and bile. In addition, 7.8 +/- 2.2 and 5.2 +/- 2.5 percent of the injected radioactivity was found in the pan water bathing the ventral surface of the venously and dorsally injected conscious frogs, respectively, suggesting transfer of radioactivity across the skin. At 2.5 hours, polar metabolites represented 50% of the radioactivity found in liver, bile, and bladder water. These polar metabolites were determined to be 18-carboxy-19,20-dinor-leukotriene E4, 20-carboxy-leukotriene E4, and 20-hydroxy-leukotriene E4. Of the non-oxidized leukotrienes, bile contained mainly LTD4 while bladder water contained primarily LTE4. N-acetyl LTE4 was not detected in any samples. The tissue distribution, elimination and metabolism of leukotrienes in the bullfrog was similar to mammalian studies and suggests evolutionary conservation of leukotriene processing.

UI MeSH Term Description Entries
D008297 Male Males
D011892 Rana catesbeiana A species of the family Ranidae (true frogs). The only anuran properly referred to by the common name "bullfrog", it is the largest native anuran in North America. Bullfrog,Bullfrogs,Rana catesbeianas,catesbeiana, Rana
D005075 Biological Evolution The process of cumulative change over successive generations through which organisms acquire their distinguishing morphological and physiological characteristics. Evolution, Biological
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013189 SRS-A A group of LEUKOTRIENES; (LTC4; LTD4; and LTE4) that is the major mediator of BRONCHOCONSTRICTION; HYPERSENSITIVITY; and other allergic reactions. Earlier studies described a "slow-reacting substance of ANAPHYLAXIS" released from lung by cobra venom or after anaphylactic shock. The relationship between SRS-A leukotrienes was established by UV which showed the presence of the conjugated triene. (From Merck Index, 11th ed) Slow Reacting Substance of Anaphylaxis
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D014316 Tritium The radioactive isotope of hydrogen also known as hydrogen-3. It contains two NEUTRONS and one PROTON in its nucleus and decays to produce low energy BETA PARTICLES. Hydrogen-3,Hydrogen 3

Related Publications

C A Pfeifer, and R A Furilla, and K Gronert, and D D Goss, and K E Romig, and C A Herman
April 1992, The Journal of experimental zoology,
C A Pfeifer, and R A Furilla, and K Gronert, and D D Goss, and K E Romig, and C A Herman
March 1988, Canadian journal of physiology and pharmacology,
C A Pfeifer, and R A Furilla, and K Gronert, and D D Goss, and K E Romig, and C A Herman
March 1995, Canadian journal of physiology and pharmacology,
C A Pfeifer, and R A Furilla, and K Gronert, and D D Goss, and K E Romig, and C A Herman
October 1980, The Journal of experimental biology,
C A Pfeifer, and R A Furilla, and K Gronert, and D D Goss, and K E Romig, and C A Herman
January 1982, Developmental neuroscience,
C A Pfeifer, and R A Furilla, and K Gronert, and D D Goss, and K E Romig, and C A Herman
April 1972, Canadian journal of biochemistry,
C A Pfeifer, and R A Furilla, and K Gronert, and D D Goss, and K E Romig, and C A Herman
January 1988, Steroids,
C A Pfeifer, and R A Furilla, and K Gronert, and D D Goss, and K E Romig, and C A Herman
April 1995, Biochimica et biophysica acta,
C A Pfeifer, and R A Furilla, and K Gronert, and D D Goss, and K E Romig, and C A Herman
January 2003, Hearing research,
C A Pfeifer, and R A Furilla, and K Gronert, and D D Goss, and K E Romig, and C A Herman
November 2014, The Journal of comparative neurology,
Copied contents to your clipboard!